CIK: 0001792126 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value ($000): $1,024,667 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 3,156,981 | $232,796 | 22.7% | $39.31 | +100.2% | COM | 00166B105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $124,222 | 12.1% | $46.89 | -8.6% | COM | 68062P106 |
| DSGN | DESIGN THERAPEUTICS INC | 2,732,501 | $81,702 | 8.0% | $31.14 | 0.0% | COM | 25056L103 |
| DYN | DYNE THERAPEUTICS INC | 3,204,392 | $49,764 | 4.9% | $20.66 | -6.3% | COM | 26818M108 |
| — | INSTIL BIO INC | 1,846,850 | $46,319 | 4.5% | $25.08 | — | COM | 45783C101 |
| NKTX | NKARTA INC | 1,260,877 | $41,483 | 4.0% | $29.47 | +62.1% | COM | 65487U108 |
| — | FORMA THERAPEUTICS HLDGS INC | 1,410,000 | $39,508 | 3.9% | $44.61 | — | SHS | 34633R104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,056,812 | $34,346 | 3.4% | $32.43 | 0.0% | COM | 28036F105 |
| — | KINNATE BIOPHARMA INC | 934,602 | $29,122 | 2.8% | $36.41 | — | COM | 49705R105 |
| — | REPARE THERAPEUTICS INC | 900,000 | $27,621 | 2.7% | $30.58 | — | COM | 760273102 |
| — | KARUNA THERAPEUTICS INC | 200,000 | $24,046 | 2.3% | $109.05 | — | COM | 48576A100 |
| BCYC | BICYCLE THERAPEUTICS PLC | 800,000 | $23,896 | 2.3% | $29.87 | — | SPONSORED ADS | 088786108 |
| — | ATHIRA PHARMA INC | 1,010,812 | $18,599 | 1.8% | $18.46 | — | COM | 04746L104 |
| — | BIOXCEL THERAPEUTICS INC | 400,000 | $17,264 | 1.7% | $48.62 | — | COM | 09075P105 |
| CGEM | CULLINAN ONCOLOGY INC | 413,458 | $17,229 | 1.7% | $40.60 | 0.0% | COM | 230031106 |
| CYTK | CYTOKINETICS INC | 700,000 | $16,282 | 1.6% | $21.35 | 0.0% | COM NEW | 23282W605 |
| — | TURNING POINT THERAPEUTICS I | 140,000 | $13,243 | 1.3% | $94.59 | — | COM | 90041T108 |
| COGT | UNUM THERAPEUTICS INC | 1,420,500 | $12,472 | 1.2% | $10.99 | -12.4% | COM | 19240Q201 |
| — | IKENA ONCOLOGY INC | 419,853 | $11,861 | 1.2% | $28.25 | — | COM | 45175G108 |
| — | ALIGOS THERAPEUTICS INC | 476,547 | $10,837 | 1.1% | $27.65 | — | COM | 01626L105 |
| KYMR | KYMERA THERAPEUTICS INC | 260,920 | $10,139 | 1.0% | $47.58 | +26.5% | COM | 501575104 |
| — | VINCERX PHARMA INC | 480,000 | $9,264 | 0.9% | $19.30 | — | COM NEW | 92731L106 |
| CMPS | COMPASS PATHWAYS PLC | 250,000 | $9,205 | 0.9% | $34.90 | — | SPONSORED ADS | 20451W101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 550,000 | $9,191 | 0.9% | $18.72 | 0.0% | COM | 92790C104 |
| — | ASLAN PHARMACEUTICALS LTD | 2,300,000 | $7,705 | 0.8% | $3.35 | — | ADS | 04522R101 |
| — | IVERIC BIO INC | 1,200,000 | $7,416 | 0.7% | $6.18 | — | COM | 46583P102 |
| — | KINIKSA PHARMACEUTICALS LTD | 400,000 | $7,404 | 0.7% | $18.51 | — | COM CL A | G5269C101 |
| — | LANDOS BIOPHARMA INC | 734,000 | $7,068 | 0.7% | $9.63 | — | COM | 515069102 |
| PMVP | PMV PHARMACEUTICALS INC | 200,000 | $6,578 | 0.6% | $38.11 | +3.4% | COM | 69353Y103 |
| — | HARPOON THERAPEUTICS INC | 300,000 | $6,276 | 0.6% | $20.92 | — | COM | 41358P106 |
| SPRY | SILVERBACK THERAPEUTICS INC | 125,000 | $5,454 | 0.5% | $33.40 | +41.7% | COM | 82835W108 |
| — | THERAPEUTICS ACQUISITION COR | 500,000 | $5,255 | 0.5% | $14.38 | — | COM CL A | 88339T103 |
| — | BOLT BIOTHERAPEUTICS INC | 150,000 | $4,937 | 0.5% | $32.91 | — | COM | 097702104 |
| — | KEZAR LIFE SCIENCES INC | 800,000 | $4,768 | 0.5% | $5.96 | — | COM | 49372L100 |
| ANNX | ANNEXON INC | 159,622 | $4,444 | 0.4% | $23.46 | +17.2% | COM | 03589W102 |
| — | VIRACTA THERAPEUTICS INC | 470,000 | $4,348 | 0.4% | $9.25 | — | COM | 92765F108 |
| CCCC | C4 THERAPEUTICS INC | 112,928 | $4,177 | 0.4% | $29.00 | +37.2% | COM STK | 12529R107 |
| LRMR | LARIMAR THERAPEUTICS INC | 230,000 | $3,360 | 0.3% | $16.55 | +9.8% | COM | 517125100 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3,357 | 0.3% | $11.00 | — | ORD SHS | G4411D109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 100,000 | $3,304 | 0.3% | $36.46 | -3.8% | COM | 413197104 |
| — | RESEARCH ALLIANCE CORP II | 300,000 | $3,075 | 0.3% | $10.25 | — | COM CL A | 760873109 |
| — | LUCIRA HEALTH INC | 250,000 | $3,025 | 0.3% | $12.10 | — | COM | 54948U105 |
| — | FS DEVELOPMENT CORP II | 300,000 | $2,988 | 0.3% | $9.96 | — | COM CL A | 30318F100 |
| — | DECIPHERA PHARMACEUTICALS IN | 62,000 | $2,780 | 0.3% | $44.84 | — | COM | 24344T101 |
| — | CONNECT BIOPHARMA HLDGS LTD | 150,000 | $2,775 | 0.3% | $18.50 | — | ADS | 207523101 |
| — | EARGO INC | 50,000 | $2,498 | 0.2% | $44.82 | — | COM | 270087109 |
| ELDN | ELEDON PHARMACEUTICALS INC | 224,071 | $2,398 | 0.2% | $15.09 | 0.0% | COM | 28617K101 |
| — | BCTG ACQUISITION CORP | 200,000 | $2,224 | 0.2% | $10.36 | — | COM | 05492W103 |
| — | PASSAGE BIO INC | 125,010 | $2,185 | 0.2% | $14.85 | — | COM | 702712100 |
| — | ARYA SCIENCES ACQU CORP IV | 200,000 | $2,095 | 0.2% | $10.47 | — | CL A | G31659108 |
| MLTX | HELIX ACQUISITION CORP | 200,000 | $2,040 | 0.2% | $11.37 | — | COM CL A | G4444C102 |
| — | NUVATION BIO INC | 66,666 | $178 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |
| — | CEREVEL THERAPEUTICS HLDNG I | 33,333 | $144 | 0.0% | $5.64 | — | *W EXP 06/09/202 | 15678U102 |